ARCHIVES

DCT Board Approves Recompetition Of Drug Development Contracts

This article is from The Cancer Letter archive.

Vol. 19 No. 26 | June 25, 1993

Download PDF Visit The Full Archive

Related Articles

Henschke: I-ELCAP Plans to Enroll 100,000 Patients In Controversial Screening Trial

June 24, 2011

Organ Systems Meeting Canceled

November 19, 1982

FDA News: Tentative Approval Given IVAX Paxene; BMS Exclusivity Upheld

January 9, 1998

NCAB Honors Member Who Was In Stockholm

December 9, 1988

Gori Tells McGovern Committee Diet Causes Major Share Of Cancer

August 6, 1976

Spending Measures Include Provisions On Ethics For NIH Extramural Scientists.

July 11, 2008